Risk Factors, Etiology and Predictable Outcomes With Risk Stratification Scores in Acute Heart Failure Patients

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAssiut University

About this trial

Clinical Characteristics, Etiology, Short-Term Outcomes, and Performance of Contemporary Risk Stratification Scores in Acute Heart Failure Patients Presenting to Assiut University Heart Hospital.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age more than 18yrs

Clinical diagnosis of acute heart failure according to current ESC guideline criteria.

Disqualifiers

Age below than 18

Refusal to participate.

Trial population

Acute heart failure patients presenting to Emergency Department and Cardiology Department, Assiut University Hospitals, Egypt.

Trial design

Design model

Other

Time perspective

Prospective

Treatments tested in this trial

  • Echo

    Diagnostic test

    Echo for clinical assessment

  • Ecg

    Diagnostic test

    Twelve leads ECG to detect any ischemic changes

  • Creatinine

    Diagnostic test

    To detect renal function test

  • Troponin

    Diagnostic test

    Ischemic changes

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Clinical Characteristics, Etiology, Short-Term Outcomes, and Performance of Contemporary Risk Stratification Scores in Acute Heart Failure Patients Presenting to Assiut University Heart Hospital.

To externally validate the HEARTRISK6 score and evaluate its predictive performance for short-term adverse outcomes in patients with acute heart failure. History of moderate/severe valvular heart disease\_Yes. 1 Heart rate \>100 to ≤120 bpm. 2 \>120 bpm. 3 Non-invasive ventilation (NIV)BiPAP/NIV within first hour 2 Creatinine \>150 to ≤300 µmol/L 2 \>300 µmol/L. 3 Troponin \>3-5 × upper reference limit (URL) 1 \>5 × URL. 2 Failed reassessment / 3-minute walk test ifFailed1 comp0 High score means worse

Time frame
Follow up patients for 30 days

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: